NYXOAH SA
NYXHNASDAQ🏆 #4003 by market capEarnings Nov 5US Equity
$0.91▲ $0.00 (+0.02%)
Latest quoteTrack NYXH
Get earnings, price moves & breaking news on Telegram
24h▲ 0.0%
7d▲ 12.1%
14d▼ 23.6%
30d▼ 34.1%
ytd▼ 80.1%
1y▼ 82.0%
🏦Market Cap
$93M
Small Cap
📈Revenue Growth (YoY)
121.6%
High Growth
📊Gross Margin
51.3%
Healthy
💵FCF Margin
-326.1%
Thin
⚖️P/S Ratio
3.6x
Fair
Otter Score
—
Insufficient data
Trading Snapshot
- Day Range
- $0.90 – $0.92
- 52-Week Range
- $0.80 – $5.92
- Volume (shares)
- 370
- Avg Volume (shares)
- —
- Shares Outstanding
- 101.8M
- Next Earnings
- 2026-11-05
Fundamentals Snapshot
- Annual Revenue
- $10M
- Last Q Revenue
- $8M
- P/E Ratio
- -0.4
- P/S Ratio
- 3.6x
- EPS (TTM)
- $-1.73
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +8.3%
NYXOAH SA
NYXHFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$10M▲ +121.6% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
63.1%▼ −3.9% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$83M▲ +41.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$68M▲ +23.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
40.1M▲ +8.3% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$10M▼ −$22M YoY
StockOtter · stockotter.spaceAbout NYXOAH SA
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
💧Dilution★★★★★
Overall Score
Insufficient data
—/100
Analyst Ratings
ⓘConsensus
Buy
13 analysts
Strong Buy4
Buy6
Hold3
Sell0
Strong Sell0
Ratings as of Oct 2026
Latest News & Updates
News unavailable.